Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Neonatal Care ; 20(3): 216-222, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31922972

RESUMO

BACKGROUND: While women in the Deep South area of the United States have higher rates of maternal and infant mortality, palliative and supportive care programs are lacking. Additionally, few studies have detailed referral triggers that are specific to the mother, infant, or pregnancy for inclusion in perinatal and neonatal palliative and supportive care programs. PURPOSE: The purpose of this retrospective, descriptive study was to examine the sociodemographic factors and referral triggers for perinatal-neonatal palliative and supportive care services for women enrolled in a newly developed perinatal-neonatal palliative and supportive care program. METHODS: Data were collected from medical records of 135 women enrolled in the program. Triggers for referral to the program were classified as fetal, maternal, or prenatal complications. RESULTS: A diverse sample of women were enrolled in the program. Most infants survived to birth and discharge from the hospital. Two-thirds of referrals were related to infant complications and 34% were for multiple complications (fetal, maternal, and/or prenatal). Triggers for referral to the program were not related to sociodemographic characteristics of women. IMPLICATIONS FOR PRACTICE: A comprehensive list of triggers that include maternal and prenatal complications, in addition to infant complications, may ensure at-risk women and infants, are enrolled in perinatal-neonatal palliative and supportive care programs early in pregnancy, regardless of sociodemographic factors. IMPLICATIONS FOR RESEARCH: Prospective research on the effectiveness of perinatal-neonatal palliative and supportive care programs in diverse populations of women is needed. This includes the examination of family health outcomes and provider perspectives.


Assuntos
Cuidados Paliativos na Terminalidade da Vida , Cuidados Paliativos , Assistência Perinatal/métodos , Sistemas de Apoio Psicossocial , Adulto , Feminino , Necessidades e Demandas de Serviços de Saúde , Cuidados Paliativos na Terminalidade da Vida/métodos , Cuidados Paliativos na Terminalidade da Vida/organização & administração , Humanos , Lactente , Cuidado do Lactente/métodos , Mortalidade Infantil , Recém-Nascido , Mortalidade Materna , Cuidados Paliativos/métodos , Cuidados Paliativos/organização & administração , Cuidados Paliativos/psicologia , Gravidez , Estudos Retrospectivos , Serviços de Saúde Rural/organização & administração , Serviços de Saúde Rural/normas , Estados Unidos/epidemiologia
2.
Neonatal Netw ; 39(1): 24-28, 2020 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-31919290

RESUMO

When an expectant mother hears the news that her infant has a fetal anomaly, she may feel unsure of the future. A RN recognized the needs of women (and their families) expecting infants with critical fetal diagnoses and reached out to help them through their journey-through the pregnancy, delivery, and beyond. The act of walking alongside the mothers through their experience has grown into a formal program at a specialized children's and womens' hospital in the southeastern United States. This article describes the purpose of the program, how the program came into existence, and what services the program provides to this special population. The program continues to evolve, and the team members have worked with over 169 mothers to date.


Assuntos
Anormalidades Congênitas/diagnóstico , Doenças Fetais/diagnóstico , Mães/psicologia , Equipe de Assistência ao Paciente/organização & administração , Cuidado Pré-Natal/métodos , Diagnóstico Pré-Natal/psicologia , Anormalidades Congênitas/psicologia , Feminino , Humanos , Recém-Nascido , Relações Mãe-Filho , Relações Médico-Paciente , Gravidez , Diagnóstico Pré-Natal/métodos , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Revelação da Verdade , Estados Unidos
3.
Placenta ; 69: 50-56, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30213484

RESUMO

INTRODUCTION: The Liver X Receptors (LXRs) drive the transcriptional response to excess intracellular cholesterol. Oxysterols, the products of cholesterol oxidation, are activating ligands for LXR that can accumulate under conditions of oxidative stress and disrupt cholesterol homeostasis. While activation of LXR inhibits trophoblast differentiation, the impact of LXR on trophoblast physiology or cholesterol homeostasis is incompletely understood. We sought to determine if the effects of LXR activation can be ameliorated through modification of cholesterol bioavailability or inhibition of LXR-driven cholesterol efflux in trophoblasts. METHODS: We measured the effect of oxysterol exposure on BeWo cells and primary human trophoblasts (PHT cells) cultured in lipoprotein-deficient medium. We also measured the effect of the synthetic, LXR-specific ligand T0901317 on PHT cell differentiation and survival. Finally, we silenced the ATP-binding cassette transporter A1 (ABCA1), a transcriptional target of LXR that drives cholesterol efflux, to determine if inhibition of cholesterol efflux could block the effects of T0901317. RESULTS: Oxysterols inhibited BeWo survival and PHT cell differentiation, and these effects were blocked by cholesterol supplementation. T0901317 also inhibited PHT cell differentiation, and this effect was similarly blocked by cholesterol. Unlike cholesterol however, ABCA1 silencing did not modify the effect of T0901317 on PHT cell differentiation. DISCUSSION: Oxysterols and LXR inhibit trophoblast survival and differentiation exclusively in conditions of cholesterol scarcity. These findings underscore the importance of cholesterol homeostasis in the maintenance of placental function and suggest that pathways regulating cholesterol homeostasis may represent therapeutic targets to mitigate harmful sequelae of placental injury.


Assuntos
Transportador 1 de Cassete de Ligação de ATP/metabolismo , Diferenciação Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Receptores X do Fígado/agonistas , Oxisteróis/farmacologia , Trofoblastos/efeitos dos fármacos , Transportador 1 de Cassete de Ligação de ATP/genética , Diferenciação Celular/fisiologia , Linhagem Celular , Sobrevivência Celular/fisiologia , Colesterol/metabolismo , Feminino , Humanos , Hidrocarbonetos Fluorados/farmacologia , Placenta/citologia , Placenta/efeitos dos fármacos , Placenta/metabolismo , Gravidez , Sulfonamidas/farmacologia , Trofoblastos/citologia , Trofoblastos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...